Medscape March 27, 2024
Miriam E. Tucker

Data derived from continuous glucose monitoring (CGM) devices can help guide nutrition management and insulin dosing in people with type 2 diabetes (T2D) in primary care settings.

At the Advanced Technologies & Treatments for Diabetes meeting, two experts from the International Diabetes Center – HealthPartners Institute, Minneapolis, offered advice for clinicians. Tara Ettestad, RN, LD, CDCES, program manager for care transformation and training at the center, shared tips for helping patients change their diet based on CGM readings. The center’s medical director Thomas Martens, MD, provided a systematic approach to using CGM to guide adjustment of insulin doses and other medications for insulin-treated patients with T2D.

CGM-Guided Nutrition: Focus on Sustainable Changes

With CGM, people with diabetes get real-time feedback...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Clinical Trials, Digital Health, Patient / Consumer, Primary care, Provider, Technology, Trends, Wearables
Q&A: Bring your own device: How patients own tech is being used in clinical trials
AR and VR Have Potential to Reshape Wearable Tech Landscape
Ultrahuman Opens U.S. Manufacturing Facility for Wearable Rings
The Iyo One earbuds are the latest in wearable AI
Emerging Trends in Pain Management Technologies

Share This Article